Add BrightSurf on Google Email

JCI Journals


JCI early table of contents for July 25, 2013

Researchers found that rapamycin increased longevity in mice by reducing cancer rates and improving memory and spatial learning. However, the drug had limited effects on age-related symptoms such as cardiovascular function, muscle mass, and balance. The study suggests that rapamycin may be useful for treating some age-related conditions.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 25, 2013

Adenosine therapy reduces seizures and progression of epilepsy

Researchers have discovered that adenosine therapy can reduce seizures and slow the progression of epilepsy by targeting epigenetic changes in the brain. By delivering adenosine directly to the brain, scientists were able to reverse DNA hypermethylation, which is a key factor in the development of epilepsy.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 25, 2013

A lifespan-extending drug has limited effects on aging

Rapamycin treatment improved memory, reduced thyroid follicle size, and decreased cancer rates in older mice. However, its effects were age-independent, with similar benefits seen in young mice, suggesting a potential use for relieving some age-related conditions.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 25, 2013

JCI early table of contents for July 15, 2013

Research identifies a link between the FTO gene and increased hunger-stimulating hormone production in individuals prone to obesity. Additionally, studies show that adult brown fat levels increase with cold exposure, which may provide a new strategy for combating obesity.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 15, 2013

JCI early table of contents for July 8, 2013

Researchers found that macrophages are essential for embryo implantation in the uterus. The absence of these cells leads to reduced hormone levels, causing embryos to fail to implant. Restoration of macrophage function or hormone replacement therapy can revive pregnancy, shedding new light on a potential cause of infertility.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 8, 2013

Immune cells play a role in early pregnancy

Researchers found that macrophages help regulate corpus luteum development during embryo implantation, which is essential for successful pregnancy. The absence of macrophages can lead to infertility due to disrupted hormone levels, but restoring them or administering hormones can correct this issue.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 8, 2013

JCI early table of contents for July 1, 2013

Researchers have made significant progress in developing new gene therapies to treat Sickle Cell Disease, malaria, and Mucopolysaccharidosis Type IIIA. In the Journal of Clinical Investigation, scientists successfully delivered a replacement gene to the brain in mice and dogs with MPSIIIA using intra-cerebrospinal fluid gene therapy.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 1, 2013

Potential gene therapy for Sickle cell disease

Researchers have successfully used a genetic vector to efficiently transduce bone marrow cells from SCD patients, suggesting a potential treatment method. The study's findings support the use of autologous HSC transplant with genetically modified patient cells to treat sickle cell disease.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 1, 2013

A prenatal trigger for postnatal obesity

Research in Finland and mice found a prenatal link between intrahepatic cholestasis of pregnancy and increased child obesity risk. Teenagers born to mothers with the condition had altered metabolic profiles and higher BMI. A mouse model also revealed offspring were more susceptible to metabolic disease and diet-induced obesity.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 24, 2013

JCI early table of contents for June 24, 2013

A study finds a link between prenatal ICP and postnatal obesity in offspring, while another investigation reveals genetic changes in preeclampsia and brain inflammation caused by chronic cannabis use. These findings may have implications for understanding and treating metabolic diseases and pregnancy complications.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 24, 2013

Modified immune cells seek and destroy melanoma

Researchers engineered dendritic cells to recognize protein fragments from cancer-specific antigens, eliciting an immune response that led to partial and complete clinical responses in patients with active disease. The study suggests a promising approach for enhancing immune recognition of melanoma cells.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 24, 2013

Scouring the genome of adenoid cystic carcinoma

Researchers identified a genetic translocation that can precipitate disease in adenoid cystic carcinoma, with many disease-associated mutations occurring in genes modifying DNA. Identifying individual mutations will aid in the development of personalized therapy, according to accompanying commentary.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 17, 2013

JCI early table of contents for June 17, 2013

Researchers identified a genetic translocation that can precipitate disease in adenoid cystic carcinoma patients. They also found that variants in the SIM1 gene are associated with severe obesity, while vitamin B3 blocks cyst formation in a mouse model of polycystic kidney disease.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 17, 2013

JCI early table of contents for June 10, 2013

Researchers found that HDAC3 is essential for DNA replication in hematopoietic progenitor cells and plays a critical role in Alzheimer's disease pathogenesis by binding to the cellular protein FCγRIIb, which activates cell stress and death pathways. The study also identified a link between FCγRIIb and memory impairment in AD patients.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 10, 2013

Preventing an immune overreaction

Researchers develop nanoparticles to block immune responses, enabling precise control of the immune system. The study's findings suggest a new approach to treating autoimmune diseases and allergies by targeting specific immune cells.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 3, 2013

JCI early table of contents for June 3, 2013

Scientists use antigen-decorated nanoparticles to prevent immune over-reaction in mice, while also developing a potential gene therapy for Mucopolysaccharidosis Type IIIA. Meanwhile, researchers discover a new target for castration-resistant prostate cancer by blocking mutant androgen receptors.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 3, 2013

New fluorescent tools for cancer diagnosis

Researchers at Rockefeller University have developed a multicolor fluorescence labeling method to visualize miRNAs in tissue sections, enabling the identification of tumor-specific miRNAs and distinguishing between different tumor types. This technology shows promise as a molecular diagnostic tool for clinical settings.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 24, 2013

JCI early table of contents for May 24, 2013

Researchers have discovered that targeting regulatory T cells can help eliminate cancer cells, while a new fluorescence labeling method enables the visualization of microRNAs in tissue sections. Additionally, studies suggest that malnourishment exacerbates Giardia infection in mice, leading to severe gastrointestinal problems and growt...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 24, 2013

Hot on the TRAIL of graft vs. host disease

Researchers at Memorial Sloan-Kettering Cancer Center have discovered that expression of TRAIL in transplanted hematopoietic stem cells is critical for an effective anti-tumor response. This finding has led to the development of new therapeutic strategies to suppress graft-versus-host disease while maintaining anti-tumor activity.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 15, 2013

JCI early table of contents for May 15, 2013

Two studies published in the Journal of Clinical Investigation found that chemokine stimulation is not required for T cell migration to transplanted organs. Instead, immune-stimulating proteins expressed by the organ direct T cells to migrate. Additionally, researchers identified a protein called TRAIL that causes cell death and can be...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 15, 2013

JCI early table of contents for May 8, 2013

Gene replacement in pigs alleviates intestinal obstruction associated with cystic fibrosis. In contrast, Alzheimer's disease is characterized by the removal of synaptic protein ADAM10. These findings provide insight into pathophysiology and suggest tissue-specific gene replacement can alleviate CF symptoms.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 8, 2013

JCI early table of contents for May 1, 2013

Researchers identified a specific pattern of DNA modifications dependent on HPV presence that correlates with improved survival in patients with OPSCC. A new combination therapy for PEL was found to reactivate virus-induced cell lysis and induce cancer cell death, increasing mouse lifespan.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 1, 2013

Searching for therapeutic synergy in primary effusion lymphoma

Researchers found that a Bortezomib/Vorinostat combination therapy reactivated virus-induced cell lysis and induced PEL cell death, increasing the lifespan of mice with PEL tumors. This treatment combination could potentially be beneficial for immunocompromised patients with KSHV-associated malignancies.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 1, 2013

No rebirth for insulin secreting pancreatic beta cells

Researchers used fluorescent cell labeling to determine when precursor cells develop into pancreatic beta cells. They found no evidence of neogenesis in adult mice, contradicting previous assumptions about beta cell creation. This discovery has significant implications for understanding diseases like diabetes.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 24, 2013

JCI early table of contents for April 24, 2013

Researchers at Cedars-Sinai Medical Center discovered that the renin angiotensin system plays a fundamental role in hypertension. They found that mice without ACE in their kidneys were resistant to high blood pressure, indicating that targeting angiotensin production may be an effective approach to treat hypertension. In contrast, stud...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 24, 2013

JCI early table of contents for April 15, 2013

Researchers have identified the molecular mechanisms behind two rare diseases: giant axonal neuropathy and ovarian cancer. In GAN, mutations in gigaxonin disrupt neural protein degradation, leading to neurofilament accumulation. Meanwhile, ATP11B facilitates cisplatin resistance in ovarian cancer cells by mediating platinum export.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 15, 2013

JCI early table of contents for April 8, 2013

Researchers identify ATRX as a crucial gene in maintaining genomic stability, preventing chromosomal mutations and rearrangements that can cause disease and aging. Atrx deficiency in mice leads to increased DNA damage, endocrine dysfunction, shortened lifespans, and degenerative phenotypes similar to human premature aging disorders.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 8, 2013

JCI early table of contents for April 1, 2013

Researchers at Yale University have identified a protein MKP-5 as a negative regulator of muscle stem cell function, enhancing muscle regeneration in a mouse model of Duchenne muscular dystrophy. Additionally, studies suggest that lactate supports neuronal function and may protect the brain during hypoglycemia.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 1, 2013

Alternative fuel for your brain

Researchers found that recurrent hypoglycemia enhances neuronal uptake of lactate, allowing the brain to retain normal neural activity. This suggests that lactate supports neuronal function and indicates potential benefits of supplementing alternative fuels during hypoglycemia.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 1, 2013